These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2959409)

  • 41. Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
    Dowlatshahi K; Mehta RG; Thomas CF; Dinger NM; Moon RC
    Cancer Lett; 1989 Oct; 47(3):187-92. PubMed ID: 2534548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate.
    Bhatnagar R; Abou-Issa H; Curley RW; Koolemans-Beynen A; Moeschberger ML; Webb TE
    Biochem Pharmacol; 1991 May; 41(10):1471-7. PubMed ID: 1826840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone.
    Lowe NJ; Prystowsky JH; Bourget T; Edelstein J; Nychay S; Armstrong R
    J Am Acad Dermatol; 1991 Apr; 24(4):591-4. PubMed ID: 1827799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of psoriasis with an orally administered effective new vitamin A acid derivative. Preliminary report].
    Ott F; Bollag W
    Schweiz Med Wochenschr; 1975 Apr; 105(14):439-41. PubMed ID: 1091969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.
    Sani BP; Shealy YF; Hill DL
    Carcinogenesis; 1995 Oct; 16(10):2531-4. PubMed ID: 7586162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
    Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL
    Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
    Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM
    Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unusual acute, nonallergic eruptions of the scalp from combined use of minoxidil and retinoic acid.
    Fisher AA
    Cutis; 1993 Jan; 51(1):17-8. PubMed ID: 8419103
    [No Abstract]   [Full Text] [Related]  

  • 49. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice.
    Hultin TA; May CM; Moon RC
    Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer.
    Baglietto L; Torrisi R; Arena G; Tosetti F; Gonzaga AG; Pasquetti W; Robertson C; Decensi A
    Cancer Detect Prev; 2000; 24(4):369-75. PubMed ID: 11059568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retin-A and wax epilation.
    Goldberg NS; Zalka AD
    Arch Dermatol; 1989 Dec; 125(12):1717. PubMed ID: 2531572
    [No Abstract]   [Full Text] [Related]  

  • 52. Allergic contact dermatitis to retinoic acid.
    Nordqvist BC; Mehr K
    Contact Dermatitis; 1977 Feb; 3(1):55-6. PubMed ID: 139288
    [No Abstract]   [Full Text] [Related]  

  • 53. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study.
    Tanew A; Guggenbichler A; Hönigsmann H; Geiger JM; Fritsch P
    J Am Acad Dermatol; 1991 Oct; 25(4):682-4. PubMed ID: 1838750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats.
    Pollard M; Luckert PH
    Cancer Lett; 1991 Aug; 59(2):159-63. PubMed ID: 1832081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contact dermatitis due to topical retinoic acid.
    Tosti A; Guerra L; Morelli R; Piraccini BM
    Contact Dermatitis; 1992 Apr; 26(4):276-7. PubMed ID: 1395579
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture.
    Mehta RG; Hultin TA; Moon RC
    Biochem J; 1988 Dec; 256(2):579-84. PubMed ID: 2851995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological activity of novel retinamide and retinoate derivatives.
    Um SJ; Kwon YJ; Han HS; Park SH; Park MS; Rho YS; Sin HS
    Chem Pharm Bull (Tokyo); 2004 May; 52(5):501-6. PubMed ID: 15133197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dermatitis from retinoic acid.
    Rudzki E; Grzywa Z
    Contact Dermatitis; 1978 Oct; 4(5):305-6. PubMed ID: 154376
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
    Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M
    Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
    Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.